Journal of Clinical Psychiatry Issue 73(5)

Advancing the Treatment of Depression With Personalized Medicine

Performance Improvement CME: Diagnosing and Treating Bipolar Disorder

The Use of MAOIs in Primary Care

Effect of Tryptophan Hydroxylase Gene Polymorphism on Aggression in Major Depressive Disorder and Undifferentiated Somatoform Disorder

Overview of Violence to Self and Others During the First Episode of Psychosis

A Longitudinal Investigation of the Role of Self-Medication in the Development of Comorbid Mood and Drug Use Disorders: Findings From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)

A 30-Month Prospective Follow-up Study of Psychological Symptoms, Psychiatric Diagnoses, and Their Effects on Quality of Life in Children Witnessing a Single Incident of Death at School

Selective Serotonin Reuptake Inhibitors and Persistent Pulmonary Hypertension of the Newborn

Statin Use and Risk of Depression in Patients With Coronary Heart Disease: Longitudinal Data From the Heart and Soul Study

“On Paroxysmal Anxiety” by Édouard Brissaud (1890)

Aripiprazole Intramuscular Depot as Maintenance Treatment in Patients With Schizophrenia: A 52-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

Brain-Volume Increase With Sustained Remission in Patients With Treatment-Resistant Unipolar Depression

Continued Cannabis Use and Outcome in First-Episode Psychosis: Data From a Randomized, Open-Label, Controlled Trial

Managing Psychiatric Issues in Elite Athletes [CME]

Evaluation of the Glycine Transporter Inhibitor Org 25935 as Augmentation to Cognitive-Behavioral Therapy for Panic Disorder: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Varenicline for Smoking Cessation in Patients With Schizophrenia or Schizoaffective Disorder

Safety of Selegiline Transdermal System in Clinical Practice: Analysis of Adverse Events From Postmarketing Exposures

Effectiveness of Switching From Long-Acting Injectable Fluphenazine or Haloperidol Decanoate to Long-Acting Injectable Risperidone Microspheres: An Open-Label, Randomized Controlled Trial

Does the Presence of an Open-Label Antidepressant Treatment Period Influence Study Outcome in Clinical Trials Examining Augmentation/Combination Strategies in Treatment Partial Responders/Nonresponders With Major Depressive Disorder?

New Evidence for the Involvement of Mitochondrial Inheritance in Schizophrenia: Results From a Cross-Sectional Study Evaluating the Risk of Illness in Relatives of Schizophrenia Patients

Relationship Between Serum Homocysteine Levels and Depressive Symptoms: The Cooper Center Longitudinal Study

Cost and Cost-Effectiveness in a Randomized Trial of Long-Acting Risperidone for Schizophrenia

Poor Sleep at Baseline Predicts Worse Mood Outcomes in Patients With Co-Occurring Bipolar Disorder and Substance Dependence

Associated Symptoms of Attention-Deficit/Hyperactivity Disorder and Posttraumatic Stress Disorder

Comorbid Symptom Severity in Attention-Deficit/Hyperactivity Disorder: A Clinical Study

Evidence for Short-Term Psychodynamic Psychotherapy for Depression

Reply to Evidence for Short-Term Psychodynamic Psychotherapy for Depression

Allergic Reactions and Sudden Death With Asenapine

 Reply to Allergic Reactions and Sudden Death with Asenapine

Mental Health in Public Health: The Next 100 Years